https://www.selleckchem.com/pr....oducts/bi-1015550.ht
0, 25.1, and 90.0% among the GP during the study period. The dominant age population for TKA, THA, and MJA were those aged 70-79 years in both GP and RA groups. Conclusions We found an opposing trend in incidence of TKA, THA, and MJA between RA patients and the GP. The possible influence of pharmacological treatment is implicated for the lower incidence rates of TKA, THA, and MJA surgeries among RA patients.Platelets have recently emerged as important immune modulators in systemic lupus erythematosus (SLE), in addition to their role